Filing Details

Accession Number:
0001613377-17-000004
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-02-21 15:31:14
Reporting Period:
2017-02-16
Filing Date:
2017-02-21
Accepted Time:
2017-02-21 15:31:14
Original Submission Date:
2017-02-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946644 Hemispherx Biopharma Inc HEB Biological Products, (No Disgnostic Substances) (2836) 520845822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465652 S. Wayne Springate 22 St James Court
Philadelphia PA 19106
Sr Vp Of Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-16 8,014 $0.46 16,641 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17).